Non-invasive Aesthetic Treatment Market By Procedure (Injectables, Skin Resurfacing, Others), By Gender (Female, Male), By Age Group (13 to 39, 40 to 54, 55 to 69, Age 70 and Over), By End User (Specialty and Dermatology Clinics, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The global non-invasive aesthetic treatment market was valued at $15,510.94 million in 2022, and is projected to reach $37,471.03 million by 2032, registering a CAGR of 9.2% from 2023 to 2032.
Non-invasive aesthetic treatment encompasses a wide range of cosmetic procedures and therapies that enhance an individual's physical appearance and address various concerns without the need for surgical intervention. These treatments are designed to improve skin quality, reduce signs of aging, and enhance specific features, often with minimal discomfort, minimal to no downtime, and a lower risk of complications compared to invasive surgical options. Common non-invasive treatments include Botox injections, dermal fillers, laser therapy, chemical peels, and microdermabrasion, among others. These procedures typically target issues such as wrinkles, fine lines, acne scars, skin texture irregularities, and volume loss. The non-invasive aesthetic treatment industry is characterized by ongoing advancements in technology and a growing demand driven by societal pressures and the pursuit of a more youthful and appealing appearance.
The rise in awareness about non-invasive aesthetic treatment procedures, as well as the increase in adoption of this procedure among the elderly and young population for enhancing their appearance, is driving the growth of the non-invasive aesthetic treatment market. For instance, according to the International Society of Aesthetic Plastic Surgeons (IASPS), the number of non-surgical fat reduction procedures performed on individuals under the age of 18 has been steadily increasing in recent years. In 2020, the ASPS reported that there were approximately 24,488 non-surgical fat reduction procedures performed on individuals under the age of 18, which represents a 3.4% of the total non-surgical fat reduction procedures.
In addition, technological advancements play a pivotal role in driving the growth of the non-invasive aesthetics market. These innovations have revolutionized the industry by making procedures safer, more effective, and appealing to a wider range of patients. One significant impact of technological advancements is the development of non-invasive alternatives to surgical procedures. For instance, the introduction of advanced laser technology has enabled a variety of skin resurfacing and resurfacing procedures, including laser hair removal, tattoo removal, and skin tightening. These treatments often have reduced downtime, lower risk, and offer more predictable outcomes than their surgical counterparts. In addition, these advances have allowed for more comfortable and painless procedures, further encouraging patients to consider non-invasive aesthetic treatments.
However, the non-invasive aesthetics market faces growth restraints, primarily due to high costs and inconsistent results. The expense of these treatments be prohibitive for many individuals, limiting their accessibility. Moreover, inconsistent outcomes, varying from person to person, lead to patient dissatisfaction. The combination of cost concerns and uncertain results deter potential clients and affect market expansion, making affordability and effectiveness crucial considerations for both providers and patients.
The non-invasive aesthetic treatment market is segmented on the basis of procedure, gender, age group, and end user and region. On the basis of procedure, the market is classified into injectables, skin resurfacing, and others. The injectables segment is further divided into neurotoxins, HA filler and non-HA fillers. The skin resurfacing segment is further divided into chemical peel, laser skin resurfacing, and microdermabrasion. The others segment is further bifurcated into laser hair removal, non-surgical fat reduction, sclerotherapy and others. On the basis gender, the market is categorized into female and male. On the basis age group, the market is segregated into 13 to 39, 40 to 54, 55 to 69, age 70 and over. On the basis of end user, market is fragmented into specialty & dermatology clinics, hospital, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The major key players that operate in the global non-invasive aesthetic treatment market are Cynosure Inc Sisram Medical Ltd, Abbvie Inc, Lumenis Ltd., Candela Corporation, Fotona, HTM Eletronica MerzPharma., Cutera and Bausch Health Companies Inc.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non-invasive aesthetic treatment market analysis from 2022 to 2032 to identify the prevailing non-invasive aesthetic treatment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the non-invasive aesthetic treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global non-invasive aesthetic treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market SegmentsBy ProcedureInjectables
Type
Neurotoxins
Hyaluronic Acid Fillers
Non Hyaluronic Fillers
Skin Resurfacing
Type
Microdermabration
Laser skin resurfacing
Chemical peel
Others
Type
Laser Hair Removal
Nonsurgical Fat Reduction
Sclerotherapy
Others
By GenderFemale
Male
By Age Group13 to 39
40 to 54
55 to 69
Age 70 and Over
By End UserSpecialty and Dermatology Clinics
Hospitals
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market PlayersCynosure Inc
Sisram Medical Ltd.
Candela Corporation.
Fotona
HTM Eletronica
Cutera
AbbVie Inc.
Lumenis Ltd.
MerzPharma
Bausch Health Companies Inc.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.